text.skipToContent text.skipToNavigation
Need help? Please contact us

Arrayed CRISPR Screening of Primary Lung Small Airway Epithelial Cells with 384-well Nucleofector® System

We have more articles for you

Article overview

Review on the CRISPR virtual event 2022

Read our short summary of the two sessions and a roundtable with interesting insights from our CRISPR experts.

CRISPR/Cas9 based genome engineering of NK cells using Nucleofector® Technology

How to handle the natural killers for genomic engineering purposes?

Learn from the authors about the potential overcome of some limitation of NK cell-based therapies and check for the detailed protocol of Cas9 RNP transfection. 

Maybe it is also a start for you? 

Reprogramming of human erythroblasts into iPSC for Sickle Cell Disease research

The Nucleofection® Technology used for generation of three SCD-iPS and three control iPS cell lines.

Interested in our webinars?

Need a break from your daily routine? Grab a coffee and check out our free webinars. 

Knowledge Center

Need technical data?

Browse our Cell and Transfection, Citation, FAQ and Culture Media Technical Databases.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

References

Dickson A, Mullooly N, Serrano A, Escudero-Ibarz L, Wiggins C, Gianni D. Highly scalable arrayed CRISPR mediated gene silencing in primary lung small airway epithelial cells SLAS Discov. 2023 Mar;28(2):29-35


 

Important note: The user bears the sole responsibility for determining the existence of any third party rights, as well as obtaining any necessary licenses, related to performing the screening workflow, including using CRISPR/Cas9.


 

*The statements made by each of the presenters does not necessarily represent the opinions of his or her employer.